Valuation: Johnson & Johnson

Capitalization 530B 451B 418B 391B 728B 48,729B 772B 4,778B 1,897B 23,008B 1,989B 1,948B 83,692B P/E ratio 2025
18.8x
P/E ratio 2026 * 23x
Enterprise value 555B 472B 437B 409B 762B 50,987B 808B 5,000B 1,985B 24,074B 2,081B 2,038B 87,570B EV / Sales 2025
5.31x
EV / Sales 2026 * 5.45x
Free-Float
77.08%
Yield 2025 *
2.34%
Yield 2026 * 2.41%
More valuation ratios * Estimated data
Dynamic Chart
1 day+0.76%
1 week+0.68%
Current month+6.37%
1 month+6.98%
3 months+14.38%
6 months+30.18%
Current year+6.37%
More quotes
1 week 210.5
Extreme 210.5
222.17
1 month 200.91
Extreme 200.9101
222.17
Current year 200.91
Extreme 200.9101
222.17
1 year 141.5
Extreme 141.5
222.17
3 years 140.68
Extreme 140.68
222.17
5 years 140.68
Extreme 140.68
222.17
10 years 96.04
Extreme 96.04
222.17
More quotes
Manager TitleAgeSince
Chief Executive Officer 63 03/01/2022
Director of Finance/CFO 59 01/07/2018
Chief Tech/Sci/R&D Officer 61 01/08/2024
Director TitleAgeSince
Director/Board Member 72 23/10/2009
Director/Board Member 62 15/10/2013
Director/Board Member 71 09/06/2015
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+0.76%+0.68%+50.12%+30.79% 530B
-2.12%+2.49%+38.83%+211.00% 953B
+0.53%+2.29%+28.47%+47.60% 388B
+0.06%-0.23%+26.86%+17.82% 377B
+0.15%-3.36%+22.94%+23.03% 286B
+0.47%+0.03%+28.12%+35.36% 281B
+1.17%+3.20%-30.92%-16.86% 281B
-0.92%-0.60%+11.95%-1.55% 269B
-0.67%+4.34%+24.06%+32.10% 186B
+3.65%+8.82%+46.29%+63.32% 169B
Average +0.31%+1.55%+24.67%+44.26% 371.91B
Weighted average by Cap. -0.17%+1.27%+28.51%+72.76%
See all sector performances

Financials

2025 2026 *
Net sales 93.76B 79.74B 73.91B 69.07B 129B 8,614B 136B 845B 335B 4,067B 352B 344B 14,795B 101B 85.57B 79.32B 74.12B 138B 9,244B 146B 906B 360B 4,365B 377B 370B 15,877B
Net income 24.14B 20.53B 19.03B 17.78B 33.15B 2,218B 35.13B 217B 86.33B 1,047B 90.5B 88.65B 3,809B 23.37B 19.87B 18.42B 17.21B 32.09B 2,147B 34.01B 211B 83.58B 1,014B 87.62B 85.83B 3,687B
Net Debt 24.58B 20.9B 19.37B 18.1B 33.75B 2,258B 35.77B 221B 87.9B 1,066B 92.15B 90.27B 3,878B 17.99B 15.3B 14.18B 13.25B 24.7B 1,653B 26.18B 162B 64.34B 780B 67.45B 66.07B 2,839B
More financial data * Estimated data
Logo Johnson & Johnson
Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (64.1%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.; - medical products and equipment (35.9%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals; At the end of 2024, Johnson & Johnson has 64 manufacturing facilities located in the United States (23), North America (7), Europe (21), Africa and Asia/Pacific (13). The United States accounts for 56.6% of net sales.
Employees
138,100
Calendar
More about the company
Date Price Change Volume
23/01/26 220.14 $ +0.76% 6,951,040
22/01/26 218.49 $ +0.22% 13,160,041
21/01/26 218.01 $ -0.09% 14,762,883
20/01/26 218.21 $ -0.21% 14,057,136
16/01/26 218.66 $ -0.41% 10,021,515

Delayed Quote Nyse, 24 January 2026 at 08:00 am AEDT

More quotes
Trader
Investor
Global
Quality
ESG MSCI
BBB
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
220.14USD
Average target price
224.08USD
Spread / Average Target
+1.79%
Consensus

Quarterly revenue - Rate of surprise